Etanercept In Juvenile Idiopathic Arthritis - R... Apr 2026

Since its FDA approval in 1999, (Enbrel) has served as a cornerstone biologic therapy for children with Juvenile Idiopathic Arthritis (JIA) who do not respond sufficiently to standard treatments like methotrexate. Clinical Effectiveness Across JIA Subtypes

Etanercept is a TNF-alpha inhibitor that works by blocking inflammatory proteins to reduce joint swelling and pain. etanercept in juvenile idiopathic arthritis - R...